コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 sed cardiac index (<or=2.2 liters per minute per square meter).
2 ght at a flux of less than 1 sun (1 kilowatt per square meter).
3 rent sheets (tens to hundreds of nanoamperes per square meter).
4 0.0001) increase in risk with each kilogram per square meter.
5 ross the ocean surface of 0.4 +/- 0.05 watts per square meter.
6 positivity and doxorubicin doses above 60 mg per square meter.
7 diac index was 1.60+/-0.35 liters per minute per square meter.
8 ndogenic heat fluxes locally reaching 1 watt per square meter.
9 idopsis leaves at 10-15 nmol AtRAF1 monomers per square meter.
10 ne-of-sight column densities of about 10(20) per square meter.
11 lerated dose of interleukin-2 was 1x10(6) IU per square meter.
12 ice flow, packed at densities of ten animals per square meter?
13 S from 1983 to 2001 at a rate of 0.16 watts per square meter (0.10%) per year; this change is a comb
14 effect of body mass index (BMI, in kilograms per square meter) 5 years before diagnosis on risk of de
16 ecreased significantly from baseline (-7.7 g per square meter; 95% confidence interval [CI], -15.4 to
17 esults of a high-resolution (>/=nine returns per square meter) airborne light detection and ranging (
19 up (mean improvement over baseline, -14.1 ml per square meter and -14.6 ml per square meter, respecti
20 acement (mean changes from baseline, -9.0 ml per square meter and -6.5 ml per square meter, respectiv
21 ce response with a threshold of 10(-9) moles per square meter and is not reversible by far red light.
22 c coefficients (e(31,f) = -27 +/- 3 coulombs per square meter) and figures of merit for piezoelectric
23 The correlation between dose (millicuries per square meter) and thrombocytopenia was made stronger
24 c flow (6.2 +/- 2.4 versus 9.4 +/- 3.4 L/min per square meter), and peak arch velocity (1.9 +/- 0.7 v
25 status, body mass index (BMI) (in kilograms per square meter), and resource utilization band (RUB) (
28 weeks every six weeks; fluorouracil (425 mg per square meter as an intravenous bolus) and leucovorin
29 an intravenous bolus) and leucovorin (20 mg per square meter as an intravenous bolus) daily for five
30 an intravenous bolus), and leucovorin (20 mg per square meter as an intravenous bolus) weekly for fou
31 ce area intravenously), fluorouracil (500 mg per square meter as an intravenous bolus), and leucovori
32 ter of body-surface area, increased to 1.0 g per square meter) as induction therapy for active lupus
34 er an 80-year fire cycle (-2.3 +/- 2.2 Watts per square meter) because multidecadal increases in surf
35 t Missions and is found to average 1.8 watts per square meter between 30 degrees S and 30 degrees N.
36 with seven daily doses of cytarabine (100 mg per square meter) by continuous intravenous infusion.
38 of body-surface area) or a high dose (90 mg per square meter), combined with seven daily doses of cy
39 eat flux (approximately 85 +/- 25 milliwatts per square meter), comparable to the average at Earth's
40 x at the top of the atmosphere was -15 watts per square meter, comparable to the aerosol indirect eff
41 sol climate forcings of as much as -0.8 watt per square meter cooling and +0.3 watt per square meter
42 estimated to be no more than about -0.3 watt per square meter (cooling), compared with +2.45 watts pe
44 of body-surface area and 750 mg of etoposide per square meter, each for 3 consecutive days, and each
48 oses) and 105 to receive dexrazoxane (300 mg per square meter) followed immediately by doxorubicin.
52 -surface area) plus cyclophosphamide (600 mg per square meter) for four cycles, followed by four cycl
54 T concentrations [grams of active ingredient per square meter (g ai/m(2))] were determined using HPLC
56 ys 1 and 29, followed by 4 g of fluorouracil per square meter given as a 96-hour infusion on days 1 a
57 r 5 days every 28 days), chlorambucil (40 mg per square meter, given orally every 28 days), or fludar
58 ts in the group assigned to 16 mg of TNFR:Fc per square meter had improvement of 20 percent or more i
59 ntation with a higher melphalan dose (200 mg per square meter) had induced only a partial, transient
60 tantaneous forcing of climate from -28 watts per square meter in cloud-free conditions to +8 watts pe
63 a in the CABG-alone group and 49.6+/-31.5 ml per square meter in the combined-procedure group (mean c
64 a in the CABG-alone group and 43.2+/-20.6 ml per square meter in the combined-procedure group (mean i
65 area in the repair group and 60.7+/-31.5 ml per square meter in the replacement group (mean change f
67 cted sunlight decreased by less than 2 watts per square meter, in the tropics over the period 1985-20
68 ntravenously on day 1) and etoposide (120 mg per square meter intravenously on days 1, 2, and 3) admi
69 very four weeks; or irinotecan alone (125 mg per square meter intravenously) weekly for four weeks ev
70 ean relationship of the numbers of parasites per square meter is very well described by TL but is not
71 t Earth is now absorbing 0.85 +/- 0.15 watts per square meter more energy from the Sun than it is emi
72 local surface heat flux changes (+/-4 watts per square meter) much larger than the basinwide average
73 vity, core heat flux is 80 to 160 milliwatts per square meter (mW m(-2)) into the coldest D'' region
74 trexate use and received 24 mg of adalimumab per square meter of body-surface area (maximum dose, 40
75 umulative procarbazine dose of 4.3 g or more per square meter of body-surface area (which has been as
76 imab maintenance therapy at a dose of 375 mg per square meter of body-surface area administered every
77 riority trial, we compared rituximab (375 mg per square meter of body-surface area administered once
78 otherapy consisting of 700 mg of carboplatin per square meter of body-surface area and 750 mg of etop
79 weeks) or dacarbazine (at a dose of 1000 mg per square meter of body-surface area every 3 weeks and
80 ither ADT plus docetaxel (at a dose of 75 mg per square meter of body-surface area every 3 weeks for
81 ministered intravenously at a dose of 175 mg per square meter of body-surface area every 3 weeks, plu
82 ry 2 weeks, or docetaxel, at a dose of 75 mg per square meter of body-surface area every 3 weeks.
83 very 2 weeks or docetaxel at a dose of 75 mg per square meter of body-surface area every 3 weeks.
84 with ALL to receive doxorubicin alone (30 mg per square meter of body-surface area every three weeks
85 d by one course of high-dose cytarabine (3 g per square meter of body-surface area for six doses).
86 , the mean (+/-SD) LVESVI was 41.2+/-20.0 ml per square meter of body-surface area in the CABG-alone
87 among surviving patients was 46.1+/-22.4 ml per square meter of body-surface area in the CABG-alone
88 among surviving patients was 54.6+/-25.0 ml per square meter of body-surface area in the repair grou
89 orally twice daily) or dacarbazine (1000 mg per square meter of body-surface area intravenously ever
90 treatment plus concurrent cisplatin (100 mg per square meter of body-surface area intravenously on d
91 ither four 28-day cycles of cisplatin (60 mg per square meter of body-surface area intravenously on d
92 domly assigned to receive irinotecan (125 mg per square meter of body-surface area intravenously), fl
93 istered twice daily at a dose of 20 to 30 mg per square meter of body-surface area on a continuous do
94 vant therapy consisting of docetaxel (100 mg per square meter of body-surface area on day 1), docetax
95 aily on days 1 through 5, 60 mg of docetaxel per square meter of body-surface area on day 2, and 60 m
96 ously plus capecitabine at a dose of 2000 mg per square meter of body-surface area on days 1 through
97 cristine with bortezomib at a dose of 1.3 mg per square meter of body-surface area on days 1, 4, 8, a
98 gned patients to receive 90 mg of paclitaxel per square meter of body-surface area on days 1, 8, and
99 us either a combination of etoposide (100 mg per square meter of body-surface area on days 2 to 4), d
100 lone or in combination with cisplatin (40 mg per square meter of body-surface area once a week for up
101 and a cardiac index of 2.7 liters per minute per square meter of body-surface area or less were rando
102 to receive 135 mg of intravenous paclitaxel per square meter of body-surface area over a 24-hour per
103 rses of intravenous cyclophosphamide (600 mg per square meter of body-surface area per course) plus e
104 ve days of treatment with 12 mg of cisplatin per square meter of body-surface area per day and 600 mg
105 citabine was administered at a dose of 20 mg per square meter of body-surface area per day for 10 con
106 ted with higher doses of bexarotene (>300 mg per square meter of body-surface area per day) and in th
107 he regimen consisted of fluorouracil (500 mg per square meter of body-surface area per day) during fr
108 reatment consisted of 425 mg of fluorouracil per square meter of body-surface area per day, plus 20 m
109 d to immediate acyclovir suppression (300 mg per square meter of body-surface area per dose orally, t
110 en plus either rituximab at a dose of 375 mg per square meter of body-surface area per week for 4 wee
111 y, noninferiority trial of rituximab (375 mg per square meter of body-surface area per week for 4 wee
112 ee chemotherapy regimens: 40 mg of cisplatin per square meter of body-surface area per week for six w
113 study compared melphalan at a dose of 200 mg per square meter of body-surface area plus autologous st
115 ean (+/-SD) 2-year LVESVI was 52.6+/-27.7 ml per square meter of body-surface area with mitral-valve
116 yeloablative chemotherapy (melphalan, 140 mg per square meter of body-surface area) and autologous st
117 mly assigned to receive gemcitabine (1000 mg per square meter of body-surface area) and carboplatin (
118 tive cycles of intravenous epirubicin (50 mg per square meter of body-surface area) and cisplatin (60
119 ltiple myeloma to receive bortezomib (1.3 mg per square meter of body-surface area) and dexamethasone
120 erformance status) to nab-paclitaxel (125 mg per square meter of body-surface area) followed by gemci
121 milliliter per minute) and paclitaxel (50 mg per square meter of body-surface area) for 5 weeks and c
122 rleukin-2 (0.3x10(6), 1x10(6), or 3x10(6) IU per square meter of body-surface area) for 8 weeks.
123 r an intravenous bolus of bortezomib (1.3 mg per square meter of body-surface area) on days 1, 4, 8,
124 atients with two cycles of rituximab (375 mg per square meter of body-surface area) once weekly for 3
125 norubicin at either the standard dose (45 mg per square meter of body-surface area) or a high dose (9
126 erapy who were receiving cisplatin (>/=70 mg per square meter of body-surface area) or cyclophosphami
127 chemotherapy with either pemetrexed (500 mg per square meter of body-surface area) or docetaxel (75
128 ce daily or intravenous dacarbazine (1000 mg per square meter of body-surface area) or paclitaxel (17
129 f intravenous cyclophosphamide (0.5 to 1.0 g per square meter of body-surface area) plus corticostero
130 ned to receive doxorubicin (60, 75, or 90 mg per square meter of body-surface area) plus cyclophospha
131 of three doses of TNFR:Fc (0.25, 2, or 16 mg per square meter of body-surface area) twice weekly for
134 the following treatments: fludarabine (25 mg per square meter of body-surface area, administered intr
135 (211 patients) at an initial dose of 400 mg per square meter of body-surface area, followed by 250 m
136 monthly intravenous cyclophosphamide (0.5 g per square meter of body-surface area, increased to 1.0
137 f intravenous paclitaxel at a dose of 175 mg per square meter of body-surface area, plus carboplatin
138 py consisted of cisplatin at a dose of 50 mg per square meter of body-surface area, plus paclitaxel a
139 x10(11), 2.2x10(11), or 4.4x10(11) platelets per square meter of body-surface area, respectively), wh
140 gave everolimus orally, at a dose of 3.0 mg per square meter of body-surface area, to achieve a trou
141 rcing during the first year (34 +/- 31 Watts per square meter of burned area), but to decrease radiat
142 ower density using acetate reached 5.6 watts per square meter of cathode surface area, which was five
143 boundary fault corresponds to 27 megajoules per square meter of dissipated energy during the earthqu
144 Body weight, body mass index (kilograms per square meter of height), and waist circumference wer
145 elds at our site emits 18 to 31 g of methane per square-meter of field area per season, potentially d
146 ge adhesion energy (approximately 2.3 joules per square meter) of Ag nanoparticles to reduced CeO2(11
147 s before docetaxel, or 12 mg of mitoxantrone per square meter on day 1 plus 5 mg of prednisone twice
148 ody-surface area on day 1), docetaxel (75 mg per square meter on day 1) plus capecitabine (825 mg per
149 a day on days 1 to 14), or docetaxel (75 mg per square meter on day 1) plus gemcitabine (1000 mg per
150 ace area on days 2 to 4), doxorubicin (40 mg per square meter on day 1), and cisplatin (40 mg per squ
152 wed by either 75 mg of intravenous cisplatin per square meter on day 2 (intravenous-therapy group) or
153 roup) or 100 mg of intraperitoneal cisplatin per square meter on day 2 and 60 mg of intraperitoneal p
154 ay 2 and 60 mg of intraperitoneal paclitaxel per square meter on day 8 (intraperitoneal-therapy group
155 for six weeks (group 1); 50 mg of cisplatin per square meter on days 1 and 29, followed by 4 g of fl
156 re meter on day 1) plus gemcitabine (1000 mg per square meter on days 1 and 8) for four cycles, with
157 apy (capecitabine alone at a dose of 2500 mg per square meter on days 1 through 14 of a 21-day cycle)
158 uare meter or topotecan at a dose of 0.75 mg per square meter on days 1 to 3, plus paclitaxel at a do
159 square meter on day 1), and cisplatin (40 mg per square meter on days 3 and 4) (EDP) every 4 weeks or
160 r of body-surface area) and cisplatin (60 mg per square meter) on day 1, and a continuous intravenous
162 rface area) followed by gemcitabine (1000 mg per square meter) on days 1, 8, and 15 every 4 weeks or
163 e meter in cloud-free conditions to +8 watts per square meter once the reduction of cloud cover is ac
164 , plus paclitaxel at a dose of 135 or 175 mg per square meter or topotecan at a dose of 0.75 mg per s
165 lus either intraperitoneal cisplatin (100 mg per square meter) or intravenous cisplatin (100 mg per s
168 d increased to 2.22+/-0.44 liters per minute per square meter (P<0.001 for the comparison with base l
169 ed further, to 2.52+/-0.55 liters per minute per square meter (P<0.001 for the comparison with base l
170 both greenhouse gases in units of milliwatts per square meter per country or microwatts per square me
171 face area per day and 600 mg of fluorouracil per square meter per day during weeks 1 and 6 of irradia
172 orally every 28 days), or fludarabine (20 mg per square meter per day for 5 days every 28 days) plus
174 two five-day cycles of fluorouracil (425 mg per square meter per day) plus leucovorin (20 mg per squ
175 square meter per day) plus leucovorin (20 mg per square meter per day) were given one month apart.
176 rface area per day, plus 20 mg of leucovorin per square meter per day, for five days, followed by 450
177 ate and grain yield reached 138 and 60 grams per square meter per day, respectively; both continued t
178 es per square meter per second; 22-150 moles per square meter per day; 16-20 hour photoperiod) in a n
179 atmospheric heating locally by about 3 watts per square meter per decade (similar in magnitude to the
181 a magnitude of 0.54 +/- 0.74 (2sigma) watts per square meter per kelvin, meaning that it is likely p
184 the following permeances, measured in moles per square meter per Pascal per second: nitrogen, 1.8 x
185 s per square meter per country or microwatts per square meter per person, a metric we term internatio
186 hours dim incandescent (INC) at 5 micromoles per square meter per second and a control treatment of 1
187 der continuous irradiation at 400 micromoles per square meter per second and under 12 hours irradianc
188 photosynthetic photon flux of 200 micromoles per square meter per second cool-white fluorescent (CWF)
190 per second CWF; (c) 12 hours 400 micromoles per square meter per second CWF plus 12 hours dim CWF at
191 er per second; (d) 12 hours [400] micromoles per square meter per second CWF plus 12 hours dim incand
192 rescent (CWF); (b) continuous 400 micromoles per square meter per second CWF; (c) 12 hours 400 microm
193 tinuous irradiation at 560 to 580 micromoles per square meter per second from either metalhalide (MH)
194 der continuous irradiation of 400 micromoles per square meter per second of photosynthetic photon flu
195 tinuous irradiation at 200 or 400 micromoles per square meter per second resulted in severe stunting
196 utants can survive under 2000 microeinsteins per square meter per second with air, although they have
197 levels of PPF (100, 200, and 400 micromoles per square meter per second) and two lamp types, metal h
198 osynthetic photon flux (PPF), 200 micromoles per square meter per second, but with phytochrome photoe
200 nd CWF plus 12 hours dim CWF at 5 micromoles per square meter per second; (d) 12 hours [400] micromol
201 etic photon fluxes (PPF, 400-2080 micromoles per square meter per second; 22-150 moles per square met
202 0 to an average of 86 kilograms of wet mass per square meter per year when the grazing assemblage is
203 Net GWP (grams of carbon dioxide equivalents per square meter per year) ranged from 110 in our conven
204 dard-blood-pressure group (-1.17 vs. -0.57 g per square meter per year, P<0.001); urinary albumin exc
205 hk0 edges are in the range of 10(-10) moles per square meters per second, two orders of magnitude fa
206 adjuvant treatment with doxorubicin (<60 mg per square meter) plus cyclophosphamide in node-positive
207 axel, administered weekly at a dose of 80 mg per square meter, plus carboplatin (AUC, 6) for six cycl
208 changes over this period of about -0.1 watt per square meter, reducing the recent global warming tha
213 t the model underestimates by 25 to 30 watts per square meter the amount of solar energy absorbed by
215 between 1.1x10(11) and 4.4x10(11) platelets per square meter, the number of platelets in the prophyl
216 pole moment of 12.5 +/- 1.4 x 10(22) amperes per square meter, three times greater than mean Cenozoic
217 adhesion energies (E(ad) >/=-15 millijoules per square meter) to mica in saline pH 3.5 to 7.5 and re
218 re meter on day 1) plus capecitabine (825 mg per square meter twice a day on days 1 to 14), or doceta
219 n days 1 and 29, and 2 g of oral hydroxyurea per square meter twice weekly for six weeks (group 2); o
220 weeks (group 2); or 3 g of oral hydroxyurea per square meter twice weekly for six weeks (group 3).
223 e meter (cooling), compared with +2.45 watts per square meter (warming) due to anthropogenic greenhou
225 a low Faraday rotation (12.0 +/- 0.7 radians per square meter), we infer negligible magnetization in
226 ter of body-surface area, followed by 250 mg per square meter weekly for the duration of radiotherapy
227 4 weeks or gemcitabine monotherapy (1000 mg per square meter) weekly for 7 of 8 weeks (cycle 1) and
228 uare meter) or intravenous cisplatin (100 mg per square meter) were administered at three-week interv
229 cta column to be ~10(-6) to 10(-5) kilograms per square meter, which is consistent with LCROSS estima
230 mer from BC in Arctic snow was about 3 watts per square meter, which is eight times the typical prein
231 ts generate approximately 1 megawatt of heat per square meter, which maintains the catalyst surface a
232 to a radiative forcing of -0.5 +/- 0.4 watts per square meter, which suggests that reaching lower car
233 arth to space increased by more than 5 watts per square meter, while reflected sunlight decreased by
235 with mitral-valve repair and 60.6+/-39.0 ml per square meter with mitral-valve replacement (mean cha
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。